Iron Triangle Partners LP
- SEC CIK
- 0001779763
- Latest filing
- Feb 17, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Iron Triangle Partners LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q4 2025 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −131,390−100.0% | Sold out | Holders |
| Q3 2025 | 131,390 | $18.4M | 2.6% | +131,390 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −146,836−100.0% | Sold out | Holders |
| Q1 2025 | 146,836 | $16.2M | 2.6% | −171,359−53.9% | Reduced | Holders |
| Q4 2024 | 318,195 | $43.4M | 5.1% | +318,195 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −200,000−100.0% | Sold out | Holders |
| Q2 2024 | 200,000 | $27.5M | 2.9% | −20,000−9.1% | Reduced | Holders |
| Q1 2024 | 220,000 | $30.3M | 3.1% | +220,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −100,089−100.0% | Sold out | Holders |
| Q4 2022 | 100,089 | $12.0M | 2.1% | −255,512−71.9% | Reduced | Holders |
| Q3 2022 | 355,601 | $37.8M | 6.6% | +5,601+1.6% | Added | Holders |
| Q2 2022 | 350,000 | $34.1M | 5.5% | +350,000 | New | Holders |